Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/2/22 → … |
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
- Abdelrahim, Maen (PI)
- Chang, Jenny C. (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Niravath, Polly A. (Key Personnel)
- Singh, Monisha (Key Personnel)
- Zhang, Jun (Key Personnel)
Project: Clinical Trial